Publications by authors named "Nina E Ottosson"

New antibacterial compounds are urgently needed, especially for infections caused by the top-priority Gram-negative bacteria that are increasingly difficult to treat. Lipid A is a key component of the Gram-negative outer membrane and the LpxH enzyme plays an important role in its biosynthesis, making it a promising antibacterial target. Inspired by previously reported ortho-N-methyl-sulfonamidobenzamide-based LpxH inhibitors, novel benzamide substitutions were explored in this work to assess their in vitro activity.

View Article and Find Full Text PDF
Article Synopsis
  • About one third of epilepsy patients experience seizures that do not respond to existing medications, highlighting the need for new treatments targeting the hK 7.2/7.3 potassium channels as a potential solution.
  • In the study, researchers tested 14 resin acid derivatives for their ability to activate these channels, revealing that the most effective ones have specific chemical structures and do not interfere with other known activators.
  • The tested compounds showed promising antiseizure effects in a zebrafish model, with fewer unwanted cardiovascular side effects compared to other treatments, suggesting they could be viable candidates for new epilepsy medications.
View Article and Find Full Text PDF
Article Synopsis
  • Voltage-gated potassium (KV) channels can be activated by negatively charged resin acids, which bind to specific sites within the channel structure to facilitate opening.
  • The research investigates how two resin-acid derivatives, Wu50 and Wu161, interact with the Shaker KV channel using computational models and electrophysiology, revealing multiple potential binding sites.
  • The unique binding dynamics and interactions of resin acids with the channel may vary depending on the channel's activated state, complicating their overall impact on channel function.
View Article and Find Full Text PDF

Dehydroabietic acid (DHAA) is a naturally occurring component of pine resin that was recently shown to open voltage-gated potassium (K) channels. The hydrophobic part of DHAA anchors the compound near the channel's positively charged voltage sensor in a pocket between the channel and the lipid membrane. The negatively charged carboxyl group exerts an electrostatic effect on the channel's voltage sensor, leading to the channel opening.

View Article and Find Full Text PDF

Many pharmaceutical drugs against neurological and cardiovascular disorders exert their therapeutic effects by binding to specific sites on voltage-gated ion channels of neurons or cardiomyocytes. To date, all molecules targeting known ion channel sites bind to protein pockets that are mainly surrounded by water. We describe a lipid-protein drug-binding pocket of a potassium channel.

View Article and Find Full Text PDF

Voltage-gated ion channels generate cellular excitability, cause diseases when mutated, and act as drug targets in hyperexcitability diseases, such as epilepsy, cardiac arrhythmia and pain. Unfortunately, many patients do not satisfactorily respond to the present-day drugs. We found that the naturally occurring resin acid dehydroabietic acid (DHAA) is a potent opener of a voltage-gated K channel and thereby a potential suppressor of cellular excitability.

View Article and Find Full Text PDF

Polyunsaturated fatty acids modulate the voltage dependence of several voltage-gated ion channels, thereby being potent modifiers of cellular excitability. Detailed knowledge of this molecular mechanism can be used in designing a new class of small-molecule compounds against hyperexcitability diseases. Here, we show that arginines on one side of the helical K-channel voltage sensor S4 increased the sensitivity to docosahexaenoic acid (DHA), whereas arginines on the opposing side decreased this sensitivity.

View Article and Find Full Text PDF